POLYMED - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.0
✅ Positive
The stock experienced a recent surge of 3% following an increased quarterly revenue, indicating positive market sentiment surrounding the company’s growth trajectory. Furthermore, the DII holding has shown an increase suggesting some institutional interest.
⚠️ Limitation
Despite the revenue growth, the Sell rating from Markets Mojo and negative Qtr Profit Variance presents significant downside risk and indicates potential future challenges for Poly Medicure. The high P/E ratio and industry PE also suggest overvaluation concerns.
📉 Company Negative News
Markets Mojo has issued a 'Sell' rating on Poly Medicure stock, signaling anticipated underperformance based on their analysis.
📈 Company Positive News
Poly Medicure reported a 16.6% year-over-year increase in Q4 revenue to Rs 441 crore, demonstrating growth in sales.
🏭 Industry
The pharmaceutical and medical devices industry is currently experiencing moderate growth driven by increasing healthcare expenditure and demand for innovative solutions, though it remains sensitive to regulatory changes and competitive pressures. Companies within this sector often trade at premium valuations due to R&D intensity and intellectual property protection.
🧾 Conclusion
Based on the chart patterns, Poly Medicure appears to be in a consolidation phase near its resistance level of 2145₹, with potential support around 1611₹ (DMA 50). An optimal entry zone could be established between 1611-1630 if the price shows signs of breaking above the current resistance. An exit strategy should target 1875 ₹ as a profit taking point or 1611₹ for risk management. Overall, the stock exhibits moderate momentum and requires careful monitoring due to the negative rating and potential revenue headwinds.